19-17360556-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031310.3(PLVAP):c.1294C>T(p.Pro432Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,614,022 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031310.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLVAP | NM_031310.3 | c.1294C>T | p.Pro432Ser | missense_variant | 5/6 | ENST00000252590.9 | NP_112600.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLVAP | ENST00000252590.9 | c.1294C>T | p.Pro432Ser | missense_variant | 5/6 | 1 | NM_031310.3 | ENSP00000252590 | P1 | |
PLVAP | ENST00000595816.1 | c.79+5417C>T | intron_variant | 3 | ENSP00000469369 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152184Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000124 AC: 31AN: 250998Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135622
GnomAD4 exome AF: 0.0000753 AC: 110AN: 1461720Hom.: 0 Cov.: 32 AF XY: 0.0000921 AC XY: 67AN XY: 727170
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152302Hom.: 1 Cov.: 31 AF XY: 0.0000671 AC XY: 5AN XY: 74478
ClinVar
Submissions by phenotype
PLVAP-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 29, 2024 | The PLVAP c.1294C>T variant is predicted to result in the amino acid substitution p.Pro432Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.091% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 16, 2022 | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 432 of the PLVAP protein (p.Pro432Ser). This variant is present in population databases (rs535533604, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PLVAP-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at